1. Home
  2. HLIT vs ZYME Comparison

HLIT vs ZYME Comparison

Compare HLIT & ZYME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmonic Inc.

HLIT

Harmonic Inc.

HOLD

Current Price

$13.80

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

Logo Zymeworks Inc.

ZYME

Zymeworks Inc.

HOLD

Current Price

$25.02

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLIT
ZYME
Founded
1988
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
1996
2022

Fundamental Metrics

Financial Performance
Metric
HLIT
ZYME
Price
$13.80
$25.02
Analyst Decision
Buy
Strong Buy
Analyst Count
4
11
Target Price
$14.67
$38.90
AVG Volume (30 Days)
1.6M
424.9K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
33.33
EPS
0.07
N/A
Revenue
N/A
$105,965,000.00
Revenue This Year
$42.73
$183.10
Revenue Next Year
$18.36
N/A
P/E Ratio
$186.21
N/A
Revenue Growth
N/A
38.87
52 Week Low
$8.47
$13.48
52 Week High
$17.68
$29.75

Technical Indicators

Market Signals
Indicator
HLIT
ZYME
Relative Strength Index (RSI) 62.53 56.90
Support Level $8.97 $24.79
Resistance Level $15.48 $27.19
Average True Range (ATR) 0.60 1.02
MACD 0.30 0.34
Stochastic Oscillator 74.40 76.29

Price Performance

Historical Comparison
HLIT
ZYME

About HLIT Harmonic Inc.

Harmonic Inc engaged in broadband access solutions that enable broadband operators to more efficiently and effectively deploy high-speed internet for data, voice, and video services for their customers and versatile and high-performance video delivery software, products, system solutions and services that enable its customers to efficiently create, prepare, store, playout and deliver a full range of high-quality broadcast and streaming video services to consumer devices, including televisions, personal computers, laptops, tablets, and smartphones. It has two segments, Broadband which provides broadband access solutions and related services, and Others; and Video business provides video processing and production and playout solutions and services, and Others.

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

Share on Social Networks: